相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Expression of SIRT1 Associates with the Doxorubicin Resistance of Breast Cancer through the Activation of Akt
Xiaoxia Jin et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells
Junyu Xiang et al.
GASTROENTEROLOGY (2020)
A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide
Rashi Minocha et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer
Qiangsheng Hu et al.
CANCER LETTERS (2019)
Effects of SIRT1 silencing on viability, invasion and metastasis of human glioma cell lines
Yu Li et al.
ONCOLOGY LETTERS (2019)
SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis
Yuanzhen Ma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-κB signaling
Xueyi Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
The SIRT2/cMYC Pathway Inhibit Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
Lei Xu et al.
NEOPLASIA (2019)
SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway
Cuisheng Zhang et al.
MOLECULAR MEDICINE REPORTS (2019)
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Michael G. Dorrington et al.
FRONTIERS IN IMMUNOLOGY (2019)
Nicotinamide in the prevention of breast cancer recurrences?
Giulia Dell’Omo et al.
Oncotarget (2019)
MYC upregulated LINC00319 promotes human acute myeloid leukemia (AML) cells growth through stabilizing SIRT6
Yanni Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition
Zhou Yang et al.
CANCER CELL INTERNATIONAL (2019)
Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice
Yun-Shan Wang et al.
HEPATOLOGY (2019)
MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3
Shanshan Huang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
The roles of sirtuins family in cell metabolism during tumor development
Shunqin Zhu et al.
SEMINARS IN CANCER BIOLOGY (2019)
Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest
Yiwang Hu et al.
ONCOLOGY LETTERS (2019)
SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy
Yingjie Zhang et al.
THERANOSTICS (2019)
SIRT5 Promotes Hepatocellular Carcinoma Progression by Regulating Mitochondrial Apoptosis
Rixin Zhang et al.
JOURNAL OF CANCER (2019)
SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
Yanlu Xiong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1
Liang Chang et al.
MOLECULAR MEDICINE REPORTS (2018)
Emerging Roles for SIRT5 in Metabolism and Cancer
Lauren R. Bringman-Rodenbarger et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Sirt3-mediated mitochondrial fission regulates the colorectal cancer stress response by modulating the Akt/PTEN signalling pathway
Yan Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling
Junhong Tian et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma
Shan Dang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Sirtuin 2 (Sirt2) Expression Predicts Lymph Node Metastasis and Poor Overall Survival of Patients with Esophageal Squamous Cell Carcinoma
Li Yan et al.
CLINICAL LABORATORY (2018)
Sirt1 protects from K-Ras-driven lung carcinogenesis
Luis Filipe Costa-Machado et al.
EMBO REPORTS (2018)
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer
Xiu-Fei Chen et al.
EMBO REPORTS (2018)
Effect of ganoderic acid D on colon cancer Warburg effect: Role of SIRT3/cyclophilin D
Zhendong Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
SIRT1 and microRNAs: The role in breast, lung and prostate cancers
Hedyieh Karbasforooshan et al.
EXPERIMENTAL CELL RESEARCH (2018)
SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway
Rong Li et al.
EXPERIMENTAL CELL RESEARCH (2018)
Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells
Wei Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells
Kun-Lin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer
Margalida Torrens-Mas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation
Wenlu Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Protective effects of SIRT6 against lipopolysaccharide (LPS) are mediated by deacetylation of Ku70
Lin Zhang et al.
MOLECULAR IMMUNOLOGY (2018)
SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer
Lu Xu et al.
ONCOLOGY REPORTS (2018)
SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion
Hongjie Sun et al.
ONCOTARGETS AND THERAPY (2018)
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Guoyu Huang et al.
ONCOTARGETS AND THERAPY (2018)
Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells
Yuanyuan Zhu et al.
ONCOLOGY LETTERS (2018)
Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner
Yun-Qian Wang et al.
NATURE COMMUNICATIONS (2018)
SIRT1 promotes formation of breast cancer through modulating Akt activity
Xiaoxia Jin et al.
JOURNAL OF CANCER (2018)
SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism
Yang Li et al.
NEOPLASIA (2018)
Upregulation of PD-L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300-mediated NF-κB signaling
Justin Lucas et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells
Sara Iachettini et al.
CELL DEATH & DISEASE (2018)
Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK
Jing Wang et al.
ONCOTARGETS AND THERAPY (2018)
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
Xin Yang et al.
CANCER RESEARCH (2018)
Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis
Yong Zhang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules
Weijie You et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells
Fengyi Liang et al.
NEUROTOXICITY RESEARCH (2017)
The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3
Z. Li et al.
ONCOGENE (2017)
SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway
L. Fu et al.
ONCOGENE (2017)
Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
Ye Xiangyun et al.
ONCOTARGET (2017)
SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes
Yan Mo et al.
FEBS Journal (2017)
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity
Sebastien Moniot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Reduced expression of SIRT2 in serous ovarian carcinoma promotes cell proliferation through disinhibition of CDK4 expression
Yanhua Du et al.
MOLECULAR MEDICINE REPORTS (2017)
Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
G. Chen et al.
ONCOGENE (2017)
Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism
Shan Huang et al.
TRANSLATIONAL ONCOLOGY (2017)
SIRT3 functions as a tumor suppressor in hepatocellular carcinoma
Xianchun Zeng et al.
TUMOR BIOLOGY (2017)
SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
Xiaolong Tang et al.
NATURE COMMUNICATIONS (2017)
SIRT3: Oncogene and Tumor Suppressor in Cancer
Margalida Torrens-Mas et al.
CANCERS (2017)
The seven faces of SIRT7
Maximilian F. Blank et al.
TRANSCRIPTION-AUSTIN (2017)
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis
Bozena Sosnowska et al.
ATHEROSCLEROSIS (2017)
The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer
Guo-Cai Yang et al.
DISEASE MARKERS (2017)
SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusion
Yan Wang et al.
APOPTOSIS (2017)
The complex role of SIRT6 in carcinogenesis
Batia Lerrer et al.
CARCINOGENESIS (2016)
SIRT6 suppresses glioma cell growth via induction of apoptosis, inhibition of oxidative stress and suppression of JAK2/STAT3 signaling pathway activation
Jun Feng et al.
ONCOLOGY REPORTS (2016)
Isoalantolactone induces apoptosis in human breast cancer cells via ROS-mediated mitochondrial pathway and downregulation of SIRT1
Ziliang Li et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Down-regulation of SIRT3 promotes ovarian carcinoma metastasis
Xue-cai Dong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
SIRT4 regulates cancer cell survival and growth after stress
Seung Min Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Shikonin induces apoptosis of lung cancer cells via activation of FOX03a/EGR1/SIRT1 signaling antagonized by p300
Yun-Ji Jeung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
Hui Jing et al.
CANCER CELL (2016)
Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential
Jasmine George et al.
CANCER RESEARCH (2016)
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Sita Kugel et al.
CELL (2016)
SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway
Long-Kuan Ran et al.
CLINICAL CANCER RESEARCH (2016)
Differential Effects of Estradiol and Bisphenol A on SET8 and SIRT1 Expression in Ovarian Cancer Cells
Laura Hayes et al.
DOSE-RESPONSE (2016)
Sirtuin 3: A Janus face in cancer (Review)
Yanlu Xiong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Human sirtuins: Structures and flexibility
Lionel Sacconnay et al.
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1)
Ming-Hung Lin et al.
MOLECULES (2016)
Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
Yujiro Nakahara et al.
ONCOLOGY (2016)
Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer
Guoyu Huang et al.
ONCOLOGY REPORTS (2016)
SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions
Abhishek Bhardwaj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer
Qingyu Shi et al.
ONCOLOGY LETTERS (2016)
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway
Lihong Bai et al.
ONCOTARGET (2016)
The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer
Wenhui Zhou et al.
CELL REPORTS (2016)
SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells
Hong-Ling Wang et al.
Asian Pacific Journal of Cancer Prevention (2015)
Sirt3 binds to and deacetylates mitochondrial pyruvate carrier 1 to enhance its activity
Lei Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Sirtuin regulation in aging and injury
Ninu Poulose et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A
Weihua Xu et al.
BIOLOGICAL CHEMISTRY (2015)
Tumour-suppressive function of SIRT4 in human colorectal cancer
M. Miyo et al.
BRITISH JOURNAL OF CANCER (2015)
Sirtuin 7 in cell proliferation, stress and disease: Rise of the Seventh Sirtuin!
Shashi Kiran et al.
CELLULAR SIGNALLING (2015)
SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer
Yoko Azuma et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Broad targeting of resistance to apoptosis in cancer
Ramzi M. Mohammad et al.
SEMINARS IN CANCER BIOLOGY (2015)
Controlling the unfolded protein response-mediated life and death decisions in cancer
Marion Maurel et al.
SEMINARS IN CANCER BIOLOGY (2015)
SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway
Yizhou Quan et al.
ONCOTARGET (2015)
SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors
Shivani Malik et al.
SCIENTIFIC REPORTS (2015)
Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors
V Mangas-Sanjuan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells
Yang Cui et al.
PLOS ONE (2015)
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis
James G. Krueger et al.
PLoS One (2015)
Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a
Shun Zhang et al.
SCIENTIFIC REPORTS (2015)
The multifaceted functions of sirtuins in cancer
Angeliki Chalkiadaki et al.
NATURE REVIEWS CANCER (2015)
Altered Sirtuin 7 Expression is Associated with Early Stage Breast Cancer
Ahmad Aljada et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2015)
SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia
Daniel Sasca et al.
BLOOD (2014)
SIRT6 Promotes COX-2 Expression and Acts as an Oncogene in Skin Cancer
Mei Ming et al.
CANCER RESEARCH (2014)
SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells
Ozkan Ozden et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
A Novel Sirtuin 2 ( SIRT2) Inhibitor with p53-dependent Pro- apoptotic Activity in Non- small Cell Lung Cancer*
Gesine Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
SIRT2 Interacts with β-Catenin to Inhibit Wnt Signaling Output in Response to Radiation-Induced Stress
Phuongmai Nguyen et al.
MOLECULAR CANCER RESEARCH (2014)
SIRT3 Expression as a Biomarker for Better Prognosis in Gastric Cancer
Kuo-Hung Huang et al.
WORLD JOURNAL OF SURGERY (2014)
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
Xiaojing Chen et al.
SCIENTIFIC REPORTS (2014)
SIRT5 desuccinylates and activates SOD1 to eliminate ROS
Zhi-Feng Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
Ethan Hoffmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
Seung Min Jeong et al.
CANCER CELL (2013)
The histone deacetylase SIRT2 stabilizes Myc oncoproteins
P. Y. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
SIRT4 Prevents Hypoxia-Induced Apoptosis in H9c2 Cardiomyoblast Cells
Ban Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano et al.
GENES & DEVELOPMENT (2013)
Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b
Jeong Kyu Kim et al.
HEPATOLOGY (2013)
Sirtuin-6-Dependent Genetic and Epigenetic Alterations Are Associated With Poor Clinical Outcome in Hepatocellular Carcinoma Patients
Jens U. Marquardt et al.
HEPATOLOGY (2013)
SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3/-catenin signaling
Juan Chen et al.
HEPATOLOGY (2013)
Discovery of Thieno[3,2-4-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3
Jeremy S. Disch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency
D. Herranz et al.
ONCOGENE (2013)
Sirt3 is a tumor suppressor in lung adenocarcinoma cells
Kui Xiao et al.
ONCOLOGY REPORTS (2013)
A fluorogenic assay for screening Sirt6 modulators
Jing Hu et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism
Melanie Gertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
Petra Simic et al.
CELL REPORTS (2013)
SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
Jiyung Shin et al.
CELL REPORTS (2013)
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis
Hongfeng Yuan et al.
BLOOD (2012)
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis
Pachiyappan Kamarajan et al.
CANCER (2012)
Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells
Keita Nakane et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Matthew F. Barber et al.
NATURE (2012)
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin
Lihua Min et al.
NATURE CELL BIOLOGY (2012)
The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun
Nagalingam R. Sundaresan et al.
NATURE MEDICINE (2012)
Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer
Minqing Wu et al.
MEDICAL ONCOLOGY (2012)
Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation
F. Wang et al.
ONCOGENE (2012)
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
V. Byles et al.
ONCOGENE (2012)
A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol
Melanie Gertz et al.
PLOS ONE (2012)
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Hyun-Seok Kim et al.
CANCER CELL (2011)
Overexpression of SIRT2 contributes tumor cell growth in hepatocellular carcinomas
Hong Jian Xie et al.
MOLECULAR & CELLULAR TOXICOLOGY (2011)
Acetylation Regulates Gluconeogenesis by Promoting PEPCK1 Degradation via Recruiting the UBR5 Ubiquitin Ligase
Wenqing Jiang et al.
MOLECULAR CELL (2011)
SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
E. L. Bell et al.
ONCOGENE (2011)
Piceatannol suppresses the migration and invasion of DU145 human prostate cancer cells
Gyoo Taik Kwon et al.
CANCER RESEARCH (2010)
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Lei Zhong et al.
CELL (2010)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
p53-Induced Growth Arrest Is Regulated by the Mitochondrial SirT3 Deacetylase
SiDe Li et al.
PLOS ONE (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
Daniel Herranz et al.
NATURE COMMUNICATIONS (2010)
SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
Tiara L. A. Kawahara et al.
CELL (2009)
Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
Eun Jung Cha et al.
CLINICAL CANCER RESEARCH (2009)
Kaempferol Induces Apoptosis in Two Different Cell Lines Via Akt Inactivation, Bax and SIRT3 Activation, and Mitochondrial Dysfunction
Gabriella Marfe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
SIRT1: roles in aging and cancer
Eun-Joo Kim et al.
BMB REPORTS (2008)
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang et al.
CANCER CELL (2008)
SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70
Nagalingam R. Sundaresan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Rui-Hong Wang et al.
MOLECULAR CELL (2008)
Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1
Sharon Wong et al.
BIOCHEMICAL JOURNAL (2007)
Sirtuins: critical regulators at the crossroads between cancer and aging
L. R. Saunders et al.
ONCOGENE (2007)
Sirtuin functions in health and disease
Hiroyasu Yamamoto et al.
MOLECULAR ENDOCRINOLOGY (2007)
Sirtuins in mammals: insights into their biological function
Shaday Michan et al.
BIOCHEMICAL JOURNAL (2007)
Altered sirtuin expression is associated with node-positive breast cancer
N. Ashraf et al.
BRITISH JOURNAL OF CANCER (2006)
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage
Chuangui Wang et al.
NATURE CELL BIOLOGY (2006)
Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins
E Michishita et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
The Sir2 family of protein deacetylases
JM Denu
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis
HY Cohen et al.
MOLECULAR CELL (2004)
An in silico approach to discovering novel inhibitors of human sirtuin type 2
AJ Tervo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
HY Cohen et al.
SCIENCE (2004)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Sirtuins: Sir2-related NAD-dependent protein deacetylases
BJ North et al.
GENOME BIOLOGY (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
BJ North et al.
MOLECULAR CELL (2003)
SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria
P Onyango et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
RA Frye
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
分享论文
